Αρχική World News Assessment of Patients’ Perspective on the Consequences of the COVID-19 Pandemic on...

Assessment of Patients’ Perspective on the Consequences of the COVID-19 Pandemic on Cancer Care

Findings from the first study that investigated perspectives of cancer patients during the COVID-19 pandemic are published by a group of oncologists from the Netherlands on 4 July 2020 in the European Journal of Cancer. The study demonstrates the significant impact of the COVID-19 crisis on cancer care with most patients being very concerned in terms of their oncological treatment or follow-up, indicating the need for psycho-oncological support during pandemic.

The authors wrote that besides limited capacity of medical care in general, the COVID-19 pandemic has specific impact on cancer care. Oncologists and patients are confronted with uncertainties about the safety of anticancer treatment during the pandemic, balancing between the risk of exposure to infection and the risks of postponing lifesaving or life-prolonging anticancer treatments.

To assess patients’ perspective on the consequences of the COVID-19 pandemic on anticancer treatment and follow-up, an online survey was developed by the Dutch Federation of Cancer Patients Organisations in close collaboration with oncologists and representatives of patient advocacy groups and the Dutch Multidisciplinary Oncology Foundation. The Dutch Federation of Cancer Patients Organisations, Dutch hospitals, Dutch Cancer Society, and cancer specific patient advocacy groups distributed the survey to patients by direct mailing, announcements on websites, and social media. The survey was open between 29 March and 18 April 2020.

The survey consisted of 20 questions on four topics: patients’ characteristics, contact with the hospital, consequences of the COVID-19 pandemic, and concerns about COVID-19.

In total, 5302 cancer patients completed the survey. Overall, 30% of patients reported consequences for their oncological treatment or follow-up. In the majority of cases it was about conversion from hospital visit to consultation by phone or video.

The most frequently adjusted treatments were chemotherapy (30%) and immunotherapy (32%).

Among patients whose treatment was delayed, 55% were very concerned about it and 63% of patients whose treatment was discontinued were very concerned about such consequence of the COVID-19 pandemic.

Consequences were independent of regional differences in COVID-19 incidence. However, patients in regions with high COVID-19 incidence were significantly more concerned than patients in other regions, independent of the treatment adjustments.

The study team underlined that the findings from this survey conducted among cancer patients in the Netherlands during the national lockdown indicate that all patients could benefit from more psycho-oncological support and information, for example by use of webinars. Additional support for patients facing the daily consequences of the COVID-19 pandemic would be beneficial.

The authors emphasized that the COVID-19 pandemic has inescapable consequences for healthcare systems and adjustments in non-COVID-19 medical care cannot be avoided. They wrote that in the near future, it will be a challenge to reorganise cancer care while still facing the COVID-19 pandemic. Furthermore, the magnitude of all adjustments of cancer care on survival and quality of life of cancer patients is still not known.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Reference

de Joode K, Dumoulin DW, Engelen V, et al. Impact of the COVID-19 pandemic on cancer treatment: the patients’ perspective. European Journal of Cancer; Published online 4 July 2020. DOI: https://doi.org/10.1016/j.ejca.2020.06.019

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...

GreaterGood’s Mask Donations Are Helping LA Family Housing Keep Homeless People Safe

Due to the COVID-19 pandemic, people everywhere are uncertain about the future of their health, safety, and economic security. Homeless people and those who...

How I Found a Meaningful Career After Cancer

Jacky Costello is the founder and owner of a house cleaning company serving the greater Tampa Bay area in Florida. Through her company's partnership with...

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

October 26, 2020, by NCI Staff Radiopharmaceuticals consist of a radioactive molecule, a targeting molecule, and a linker that joins the two. Credit: National Cancer Institute The...

FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute Myeloid Leukaemia

On 16 October 2020, the US Food and Drug Administration (FDA) granted regular approval to venetoclax (VENCLEXTA ®, AbbVie Inc. and Genentech Inc.) in...

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...